| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| 129 | 8 | 9 | - | - | - | - | - | - | - | 146 |
| 83 | 0.5 | - | - | - | - | - | - | - | - | 83.5 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| 229.5 |
| 63 |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 56.5 |
| 33.5 |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| Optic-unspecified(L) | 1,612 | 65.1% | -1.99 | 406 | 53.0% |
| AME(L) | 459 | 18.5% | -1.87 | 126 | 16.4% |
| ME(L) | 292 | 11.8% | -0.81 | 167 | 21.8% |
| CentralBrain-unspecified | 113 | 4.6% | -0.75 | 67 | 8.7% |
| upstream partner | # | NT | conns aMe6c | % In | CV |
|---|---|---|---|---|---|
| HBeyelet (L) | 4 | HA | 343.5 | 29.2% | 0.1 |
| aMe4 (L) | 9 | ACh | 314 | 26.7% | 0.6 |
| MeVPMe12 (R) | 2 | ACh | 125.5 | 10.7% | 0.1 |
| aMe12 (L) | 4 | ACh | 65.5 | 5.6% | 0.4 |
| MeVCMe1 (R) | 2 | ACh | 52 | 4.4% | 0.3 |
| OA-AL2i3 (L) | 2 | OA | 47.5 | 4.0% | 0.2 |
| aMe1 (L) | 2 | GABA | 39 | 3.3% | 0.4 |
| MeVCMe1 (L) | 2 | ACh | 35 | 3.0% | 0.3 |
| aMe6b (L) | 1 | ACh | 20 | 1.7% | 0.0 |
| aMe12 (R) | 2 | ACh | 14 | 1.2% | 0.1 |
| R8y | 5 | HA | 12.5 | 1.1% | 0.5 |
| R8_unclear | 5 | HA | 11 | 0.9% | 0.5 |
| Cm35 (L) | 1 | GABA | 10 | 0.8% | 0.0 |
| C2 (L) | 8 | GABA | 8.5 | 0.7% | 0.6 |
| MeVPMe11 (R) | 1 | Glu | 8 | 0.7% | 0.0 |
| aMe30 (L) | 2 | Glu | 7 | 0.6% | 0.4 |
| Tm5c (L) | 8 | Glu | 7 | 0.6% | 0.6 |
| Dm9 (L) | 5 | Glu | 6.5 | 0.6% | 0.7 |
| R7_unclear | 4 | HA | 6 | 0.5% | 0.7 |
| MeVPMe3 (R) | 1 | Glu | 3.5 | 0.3% | 0.0 |
| MeVPaMe2 (R) | 1 | Glu | 3.5 | 0.3% | 0.0 |
| R7p | 3 | HA | 3.5 | 0.3% | 0.2 |
| MeVPMe12 (L) | 2 | ACh | 3 | 0.3% | 0.7 |
| aMe6c (L) | 2 | Glu | 3 | 0.3% | 0.0 |
| Tm3 (L) | 4 | ACh | 3 | 0.3% | 0.3 |
| aMe_unclear (L) | 1 | Glu | 2.5 | 0.2% | 0.0 |
| R8p | 4 | HA | 2.5 | 0.2% | 0.3 |
| aMe5 (L) | 4 | ACh | 2.5 | 0.2% | 0.3 |
| T1 (L) | 2 | HA | 1.5 | 0.1% | 0.3 |
| Lat2 (L) | 2 | unc | 1.5 | 0.1% | 0.3 |
| Mi10 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm21 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| aMe2 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LT58 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| l-LNv (L) | 2 | unc | 1 | 0.1% | 0.0 |
| Cm20 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| l-LNv (R) | 1 | unc | 1 | 0.1% | 0.0 |
| MeLo2 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Mi19 (L) | 1 | unc | 0.5 | 0.0% | 0.0 |
| TmY14 (L) | 1 | unc | 0.5 | 0.0% | 0.0 |
| MeVP8 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP7 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| aMe10 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Lawf2 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Lawf1 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| aMe23 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| DNc01 (R) | 1 | unc | 0.5 | 0.0% | 0.0 |
| MeLo9 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| Cm11a (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Cm23 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVP1 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| aMe10 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| SLP249 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| downstream partner | # | NT | conns aMe6c | % Out | CV |
|---|---|---|---|---|---|
| aMe6b (L) | 1 | ACh | 168.5 | 19.2% | 0.0 |
| MeVPMe12 (R) | 2 | ACh | 118 | 13.4% | 0.1 |
| aMe1 (L) | 2 | GABA | 110.5 | 12.6% | 0.5 |
| aMe17b (L) | 3 | GABA | 59.5 | 6.8% | 0.2 |
| aMe10 (L) | 1 | ACh | 58.5 | 6.7% | 0.0 |
| aMe5 (L) | 13 | ACh | 50.5 | 5.7% | 1.1 |
| Tm3 (L) | 26 | ACh | 42.5 | 4.8% | 0.8 |
| Lawf1 (L) | 11 | ACh | 40 | 4.5% | 0.7 |
| aMe15 (L) | 1 | ACh | 30 | 3.4% | 0.0 |
| aMe4 (L) | 10 | ACh | 29 | 3.3% | 0.4 |
| C2 (L) | 11 | GABA | 15 | 1.7% | 0.6 |
| LoVP54 (L) | 1 | ACh | 13 | 1.5% | 0.0 |
| HBeyelet (L) | 4 | HA | 10 | 1.1% | 0.5 |
| MeVPMe12 (L) | 2 | ACh | 9.5 | 1.1% | 0.1 |
| Mi18 (L) | 2 | GABA | 8.5 | 1.0% | 0.9 |
| Tm5c (L) | 11 | Glu | 8.5 | 1.0% | 0.7 |
| MeVP29 (L) | 1 | ACh | 6.5 | 0.7% | 0.0 |
| l-LNv (L) | 4 | unc | 6 | 0.7% | 0.2 |
| OA-AL2i3 (L) | 2 | OA | 5.5 | 0.6% | 0.5 |
| Mi10 (L) | 4 | ACh | 5 | 0.6% | 0.7 |
| Mi1 (L) | 7 | ACh | 5 | 0.6% | 0.5 |
| aMe3 (L) | 1 | Glu | 4.5 | 0.5% | 0.0 |
| T2 (L) | 5 | ACh | 4 | 0.5% | 0.5 |
| Cm35 (L) | 1 | GABA | 3 | 0.3% | 0.0 |
| aMe6c (L) | 2 | Glu | 3 | 0.3% | 0.0 |
| aMe12 (L) | 3 | ACh | 3 | 0.3% | 0.4 |
| aMe30 (L) | 3 | Glu | 3 | 0.3% | 0.4 |
| MeLo1 (L) | 2 | ACh | 2.5 | 0.3% | 0.2 |
| MeVP39 (L) | 1 | GABA | 2.5 | 0.3% | 0.0 |
| Tm5b (L) | 3 | ACh | 2.5 | 0.3% | 0.3 |
| Dm10 (L) | 4 | GABA | 2.5 | 0.3% | 0.3 |
| Mi19 (L) | 3 | unc | 2.5 | 0.3% | 0.3 |
| aMe10 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| Tm16 (L) | 2 | ACh | 2 | 0.2% | 0.5 |
| aMe2 (L) | 2 | Glu | 2 | 0.2% | 0.5 |
| TmY3 (L) | 3 | ACh | 2 | 0.2% | 0.4 |
| Lat1 (L) | 3 | unc | 2 | 0.2% | 0.4 |
| R8_unclear | 1 | HA | 1.5 | 0.2% | 0.0 |
| Lawf2 (L) | 1 | ACh | 1.5 | 0.2% | 0.0 |
| aMe12 (R) | 1 | ACh | 1.5 | 0.2% | 0.0 |
| Mi2 (L) | 2 | Glu | 1.5 | 0.2% | 0.3 |
| Dm9 (L) | 2 | Glu | 1.5 | 0.2% | 0.3 |
| TmY10 (L) | 2 | ACh | 1.5 | 0.2% | 0.3 |
| aMe_TBD1 (L) | 1 | GABA | 1.5 | 0.2% | 0.0 |
| aMe_unclear (L) | 1 | Glu | 1.5 | 0.2% | 0.0 |
| MeVC22 (L) | 2 | Glu | 1.5 | 0.2% | 0.3 |
| TmY18 (L) | 3 | ACh | 1.5 | 0.2% | 0.0 |
| Lat2 (L) | 2 | unc | 1.5 | 0.2% | 0.3 |
| MeLo7 (L) | 3 | ACh | 1.5 | 0.2% | 0.0 |
| Dm4 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| aMe6a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm11d (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Dm3a (L) | 2 | Glu | 1 | 0.1% | 0.0 |
| aMe23 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| Mi15 (L) | 2 | ACh | 1 | 0.1% | 0.0 |
| Dm1 (L) | 2 | Glu | 1 | 0.1% | 0.0 |
| MeLo9 (L) | 2 | Glu | 1 | 0.1% | 0.0 |
| L3 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| MeVP17 (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| Tm12 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| Dm2 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| Tm5a (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| ME_unclear (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| C3 (L) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| s-LNv (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| MeVPMe13 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| MeVPMe13 (R) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| MeVCMe1 (R) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| MeVCMe1 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| MeVC1 (R) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| MeVC23 (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| DNc01 (R) | 1 | unc | 0.5 | 0.1% | 0.0 |
| MeVP3 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| T1 (L) | 1 | HA | 0.5 | 0.1% | 0.0 |
| MeVP63 (L) | 1 | GABA | 0.5 | 0.1% | 0.0 |
| aMe24 (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| MeVP43 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| MeVP51 (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| aMe17e (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |